Related Experiment Video
Updated: Aug 16, 2025

Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
Crosstalk between Methylation and ncRNAs in Breast Cancer: Therapeutic and Diagnostic Implications
Yitong Liu1, Ping Leng1, Yan Liu1
1College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu 610000, China.
Abstract:
Breast cancer, as a highly heterogeneous malignant tumor, is one of the primary causes of death among females worldwide. The etiology of breast cancer involves aberrant epigenetic mechanisms and abnormal expression of certain non-coding RNA (ncRNAs). DNA methylation, N6-methyladenosine(m6A), and histone methylation are widely explored epigenetic regulation types in breast cancer. ncRNAs are a group of unique RNA transcripts, mainly including microRNA (miRNAs), long non-coding RNA (lncRNAs), circular RNA (circRNAs), small interfering RNA (siRNAs), piwi-interacting RNA (piRNAs), etc. Different types of methylation and ncRNAs mutually regulate and interact to form intricate networks to mediate precisely breast cancer genesis. In this review, we elaborate on the crosstalk between major methylation modifications and ncRNAs and discuss the role of their interaction in promoting breast cancer oncogenesis. This review can provide novel insights into establishing a new diagnostic marker system on methylation patterns of ncRNAs and therapeutic perspectives of combining ncRNA oligonucleotides and phytochemical drugs for breast cancer therapy.
Insights
This review explores the intricate interplay between DNA methylation and non-coding RNAs (ncRNAs) in breast cancer development. Understanding these epigenetic interactions offers new avenues for breast cancer diagnostics and therapies.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Breast cancer is a heterogeneous malignancy with complex etiology.
- Aberrant epigenetic mechanisms, including DNA methylation and non-coding RNA (ncRNA) dysregulation, are implicated in its development.
- N6-methyladenosine (m6A) and histone methylation are key epigenetic modifications in breast cancer.
Purpose of the Study:
- To elaborate on the crosstalk between major methylation modifications and ncRNAs in breast cancer.
- To discuss the role of these interactions in promoting breast cancer oncogenesis.
- To provide insights into novel diagnostic markers and therapeutic strategies.
Main Methods:
- Review of existing literature on epigenetic modifications and ncRNAs in breast cancer.
- Analysis of the intricate regulatory networks formed by methylation and ncRNAs.
- Discussion of the functional roles of these interactions in cancer progression.
Main Results:
- Methylation modifications and ncRNAs engage in complex crosstalk, forming networks that drive breast cancer genesis.
- Specific interactions between methylation patterns and various ncRNAs (miRNAs, lncRNAs, circRNAs) are crucial for oncogenesis.
- These interactions play significant roles in the initiation and progression of breast cancer.
Conclusions:
- The interplay between methylation and ncRNAs is fundamental to breast cancer development.
- Targeting these epigenetic interactions may lead to novel diagnostic biomarkers based on ncRNA methylation patterns.
- Combination therapies involving ncRNA oligonucleotides and phytochemicals show promise for breast cancer treatment.
Related Concept Videos
Epigenetic Regulation
lncRNA - Long Non-coding RNAs
MicroRNAs

